# FDA 483 - Vemulkonda Koneti Rao, M.D. - October 07, 2022

Source: https://www.keypedia.com/records/483/vemulkonda-koneti-rao-md/58c62d33-f9c8-4096-8a74-ebb0cc54c3ec

> FDA 483 for Vemulkonda Koneti Rao, M.D. on October 07, 2022. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Vemulkonda Koneti Rao, M.D.
- Inspection Date: 2022-10-07
- Product Type: other
- Office Name: Philadelphia District Office
- Summary: An FDA inspection of Vemulkonda Koneti Rao, M.D., a clinical investigator in Bethesda, MD, revealed significant deviations from study protocols. The inspection found that required assessments were not performed for a majority of enrolled subjects and a serious adverse event report was submitted to the sponsor more than 24 hours after it occurred. These issues indicate a failure to conduct investigations in accordance with the signed statement of investigator.

## Related Documents

- [483 - 2025-10-29](https://www.keypedia.com/records/483/vemulkonda-koneti-rao-md/db0356a3-4cbe-4992-9aa8-78e33abbbfbb)

## Related Officers

- [investigator](https://www.keypedia.com/people/stephanie-c-mangigian/0cf25e6b-1e5d-4088-a13c-11483e2380ba)

Company: https://www.keypedia.com/companies/vemulkonda-koneti-rao-md/1077f51d-4271-4061-bde8-34e77e0e820a

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8